• Featured Product
  • KD/KO Validated

p38 MAPK Rekombinanter Antikörper

p38 MAPK Rekombinant Antikörper für WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

230263D11

Kat-Nr. : 80821-2-PBS

Synonyme

MAPK14, 230263D11, CSAID-binding protein, CSBP, CSBP1



Geprüfte Anwendungen

Produktinformation

80821-2-PBS bindet in WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA p38 MAPK und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen p38 MAPK fusion protein Ag5115
Vollständiger Name mitogen-activated protein kinase 14
Berechnetes Molekulargewicht 360 aa, 41 kDa
Beobachtetes Molekulargewicht38-42 kDa
GenBank-ZugangsnummerBC031574
Gene symbol p38 MAPK
Gene ID (NCBI) 1432
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

MAPK14(mitogen-activated protein kinase 14) is also named as SAPK2A, p38MAPK, CSBP1, RK, p38, EXIP, Mxi2, CSBP2, PRKM14, PRKM15, CSPB1, p38ALPHA and belongs to the MAP kinase subfamily. MAPK14-signaling is a central pathway for the integration of instructive signals in dendritic cells for T(H)17 differentiation and inflammation(PMID:22231518). It plays an important role in the regulation of hematopoietic stem cell self-renewal in vitro and inhibition of MAPK14 activation with a small molecule inhibitor may represent a novel approach to promote ex vivo expansion of hematopoietic stem cell(PMID:21198398). This protein has 4 isoforms produced by alternative splicing.